Product Images Fingolimod Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Fingolimod Hydrochloride NDC 16729-342 by Accord Healthcare Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 Time to 3-Month Confirmed Disability Progression – Study 1 (ITT population) - fingolimod 1

Figure 1  Time to 3-Month Confirmed Disability Progression – Study 1 (ITT population) - fingolimod 1

Fingolimod Capsules 0.5 mg Label - fingolimod label

Fingolimod Capsules 0.5 mg Label - fingolimod label

Each capsule of this medication contains 0.56 mg of Fingolimod Hydrochloride, which is equivalent to 0.5 mg of Fingolimod. The recommended dosage is documented in the package insert. It must be stored in a cool and dry place within the temperature range of 20°C to 25°C (68°F to 77°F) with permissible excursions of 15°C to 30°C (59°F to 86°F) and must be protected from moisture. A medication guide is available for reference at DG 16729-342-10. The medication is available in the form of hard gelatin capsules from Accord Healthcare, Inc. The manufacturing plant is situated at Ahmedabad - 382210, India, by Intas Pharmaceuticals Limited. The lot and expiry date data is to be coated on the blank area. Pharmacists must dispense the medication with the enclosed medication guide.*

Fingolimod chemical structure - fingolimod structure

Fingolimod chemical structure - fingolimod structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.